US Patent Litigations are now available. Check here

Explore Pfizer Ireland Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 10, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3269717Aug 9, 2023Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl1041
EP2357250Oct 6, 2021Production Of Polypeptides2
EP1789571Apr 26, 2017Production Of Polypeptides2